Middletown Life

Author: Halia Therapeutics

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit

March 2, 2026
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

December 8, 2025